Clinical Trials in Little Rock, Arkansas

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

NCT ID: NCT05099003

This clinical trial is studying a new drug called selinexor, which is being tested in combination with standard radiation therapy to treat children and young adults with newly diagnosed brain tumor...

The CONFORM Pivotal Trial

NCT ID: NCT05147792

The CONFORM Pivotal Trial is studying a new device called the CLAAS® that aims to help patients with non-valvular atrial fibrillation (AF) reduce their risk of stroke. In this trial, eligible parti...

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

NCT ID: NCT06235151

This clinical trial is exploring the use of a new imaging technique called copper Cu 64 PSMA I&T PET/CT scanning to help doctors see and evaluate prostate cancer in men who have recently been diagn...

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

NCT ID: NCT06453213

This clinical trial is studying a medication called cenobamate to see how well it works as a single treatment for adults who have been diagnosed with partial-onset seizures, which are a type of epi...

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

NCT ID: NCT06868264

The C-BEYOND clinical trial is studying two different treatment options for adults with chronic Hepatitis C virus (HCV) infection: BEM/RZR and SOF/VEL. The main goal is to find out which treatment ...

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

NCT ID: NCT06935357

This clinical trial is studying a medicine called felzartamab to see how it affects adults with a kidney condition known as immunoglobulin A nephropathy (IgAN). Specifically, the researchers want t...

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

NCT ID: NCT00736749

This clinical trial is focused on following up with patients who have been part of studies conducted by the Children's Oncology Group, which is a group that researches treatments for children's can...

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

NCT ID: NCT02954094

The TARGET-HCC study is a research project that focuses on understanding how patients with hepatocellular cancer (HCC) are treated and managed in real-life situations. This study aims to collect in...

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

NCT ID: NCT03253263

This clinical trial is studying a new medication called OHB-607, which aims to help prevent a serious lung condition known as Bronchopulmonary Dysplasia (BPD) in extremely premature infants. BPD is...

Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

NCT ID: NCT05334784

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

NCT ID: NCT05778188

This clinical trial is studying a new treatment called RLS-0071 for newborns who have moderate or severe hypoxic-ischemic encephalopathy (HIE), a condition caused by a lack of oxygen to the brain d...

Behavioral Pharmacology of Cannabis in Older Adults

NCT ID: NCT06055309

This clinical trial, called the "Behavioral Pharmacology of Cannabis in Older Adults," is looking at how cannabis affects older adults in several ways, including their mood, thinking abilities, bal...

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

NCT ID: NCT06072781

This clinical trial is looking at a new treatment for women with recurrent low-grade serous ovarian cancer (LGSOC), which means the cancer has come back after previous treatments. The study is test...

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

NCT ID: NCT06292013

The ACCLAIM-Lp(a) trial is studying a new treatment called lepodisiran to see if it can help reduce the risk of serious heart problems in adults who have high levels of a substance called lipoprote...

A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

NCT ID: NCT06538116

This clinical trial is studying a new medication called mevidalen (LY3154207) to see if it is safe and effective for people with mild to moderate Alzheimer's disease. The goal is to find out if thi...

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06598943

This clinical trial is looking at two medications, eltrekibart and mirikizumab, to see how safe and effective they are for adults with moderately to severely active ulcerative colitis (UC). Ulcerat...

A U.S. Registry of Eosinophilic Esophagitis Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

NCT ID: NCT06693531

This clinical trial is looking at how well a medication called DUPIXENT® (dupilumab) works for people with eosinophilic esophagitis (EoE), a condition that affects the esophagus and can make swallo...

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

NCT ID: NCT06739122

This clinical trial, called AWARD-PEDS PLUS, is studying how different doses of a medication called dulaglutide can help children and teenagers with Type 2 diabetes. The main goal is to find out if...

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

NCT ID: NCT06809595

This clinical trial is studying a new treatment called MM120 for people with Generalized Anxiety Disorder (GAD), which is a condition where individuals often feel excessive worry or anxiety about e...

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

NCT ID: NCT06810505

This clinical trial is studying a medication called atogepant to see how well it can help prevent chronic migraines in teenagers aged 12 to 17. Chronic migraines are severe headaches that can happe...